EAT is up +49.38%% since April’24 pick View All Top Buy Picks

BriaCell Therapeutics Corp. Stock Insider Power

Based on the 30 latest insides trades, we have calculated the insider power to be positive at 94.18. In total, the insiders bought 3 087 972 and sold 0 BCTX shares in the last 30 trades.

Insider Power

(Last 30 transactions)
94.18
Buy 3 087 972 Shares
Sell 0 Shares

Historical Insider Trades

Date Type Action Person Amount
May 14, 2024 Common Shares Buy Lustig Marc 902 935
May 14, 2024 Common Stock Warrants Buy Lustig Marc 902 935
Dec 28, 2022 Common Shares Buy Bondarenko Jamieson 28 000
Dec 23, 2022 Warrant Buy Williams William V. 2 530
Dec 20, 2022 Common Shares Buy Bondarenko Jamieson 22 000
Aug 01, 2022 Common Shares Buy Bondarenko Jamieson 0
Aug 01, 2022 Option (Right to Buy) Buy Bondarenko Jamieson 250 000
Aug 01, 2022 Common Shares Buy Lustig Marc 0
Aug 01, 2022 Stock Option Buy Del Priore Giuseppe 150 000
Aug 01, 2022 Option (Right to Buy) Buy Taub Rebecca 10 000
Aug 01, 2022 Stock Option Buy Lopez-lago Miguel A. 15 000
Aug 01, 2022 Common Shares Buy Schmieg Martin E. 0
Aug 01, 2022 Option (Right to Buy) Buy Schmieg Martin E. 50 000
Aug 01, 2022 Common Shares Buy Embro-pantalony Vaughn C. 0
Aug 01, 2022 Option (Right to Buy Buy Embro-pantalony Vaughn C. 50 000
Aug 01, 2022 Common Shares Buy Williams Williams V. 0
Aug 01, 2022 Option (Right to Buy) Buy Williams Williams V. 22 300
Aug 01, 2022 Option (Right to Buy) Buy Gross Jane A 50 000
Aug 01, 2022 Common Shares Buy Levin Gadi 0
Aug 01, 2022 Option (Right to Buy) Buy Levin Gadi 20 000
Jul 14, 2022 Warrant Buy Williams Williams V. 27 272
Feb 07, 2022 Warrant Buy Lustig Marc 20 000
Nov 01, 2021 Option (Right to Buy) Buy Gross Jane A 10 000
Aug 12, 2021 Warrant Buy Bondarenko Jamieson 70 000
Mar 29, 2021 Option (Right to Buy) Buy Bondarenko Jamieson 150 000
Click to get the best stock tips daily for free!

About BriaCell Therapeutics Corp.

BriaCell Therapeutics . BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immun... BCTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT